Orthocell Ltd (ASX:OCC, OTC:ORHHF) MD Paul Anderson speaks with Proactive soon after welcoming Professor Fiona Wood AM to its board, as the company drives global commercialisation plans for its revenue generating world-leading medical devices and cellular therapies. Earlier in the quarter the company appointed new chairman John Van Der Wielen. In a move that solidifies their partnership, Orthocell and the University of Western Australia (UWA) inked a royalty agreement under which UWA has agreed to exchange all royalty entitlements for equity in Orthocell. Plus, the company also reported increasing total revenue to $1.77 million in Q1 FY24 - up 71% from Q1 FY23 of $1.03 million.
Orthocell on the cusp of significant growth
